Epoch Biodesign: Funding, Investors & Team (Sep 2026)
Epoch Biodesign specializes in creating environmentally friendly solutions to address climate-related issues by leveraging biology at an industrial level. By merging their profound knowledge in computational and biological sciences with invaluable insights from nature, the company designs enzymes that pave the way for groundbreaking applications. Their primary focus is on biorecycling, an adjustable enzymatic technique capable of transforming plastic waste into various commonly used chemicals.
Epoch Biodesign has raised $18.3M across 2 funding rounds on record, the most recent a Series A of $18.3M announced in Mar 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Epoch Biodesign Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Epoch Biodesign Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Epoch Biodesign announced an undisclosed round in Jan 2024; the amount was not disclosed.
1.2 years later, a Series A of $18.3M was announced in Mar 2025.
Epoch Biodesign Founders and Leadership Team
Contact details for the Epoch Biodesign team: 1 of 2 have an email address on file.
Start 14-day free trial →Epoch Biodesign Funding Compared to Other Biotechnology Startups
Epoch Biodesign's latest round of $18.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Epoch Biodesign in Biotechnology and London
Companies Similar to Epoch Biodesign
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Epoch Biodesign Funding FAQs
What does Epoch Biodesign do?
Epoch Biodesign specializes in creating environmentally friendly solutions to address climate-related issues by leveraging biology at an industrial level. By merging their profound knowledge in computational and biological sciences with invaluable insights from nature, the company designs enzymes that pave the way for groundbreaking applications. Their primary focus is on biorecycling, an adjustable enzymatic technique capable of transforming plastic waste into various commonly used chemicals.
How much funding has Epoch Biodesign raised?
Epoch Biodesign has raised $18.3M across 2 rounds on record. The most recent is a Series A of $18.3M announced in Mar 2025.
When did Epoch Biodesign last raise funding?
Epoch Biodesign's most recent funding round on record is a Series A of $18.3M, announced in Mar 2025.
Who founded Epoch Biodesign?
FundedIQ lists Douglas Kell (Founder), Jacob Nathan (Founder) at Epoch Biodesign.
Where is Epoch Biodesign headquartered?
Epoch Biodesign is based in London, England, United Kingdom.
How many employees does Epoch Biodesign have?
Epoch Biodesign is in the 11-50 employee band.
How does Epoch Biodesign's funding compare to other Biotechnology startups?
Epoch Biodesign's latest round of $18.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Epoch Biodesign Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Epoch Biodesign is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.